Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|9|1167-1180

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.9, 2005-04, pp. : 1167-1180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agonists of luteinizing hormone-releasing hormone in prostate cancer

By Rick Ferenc G   Block Norman L   Schally Andrew V  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2237-2247

Informa Healthcare

Access to resources Recommend Favorite

Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer

By Liu Stephen V   Liu Shanshan   Pinski Jacek  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 769-778

Informa Healthcare

Access to resources Recommend Favorite

Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 5, 2004-10 ,pp. : 459-470

Bentham Science Publishers

Access to resources Recommend Favorite

Thyrotropin-Releasing Hormone Analogs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 221-226

Bentham Science Publishers

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonists

By Herbst K.L.  

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 660-666

Elsevier

Access to resources Recommend Favorite